Silver Lake Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Hold |
752
| – | – | 0.13% | 89 |
|
|
2025
Q1 | $374K | Hold |
752
| – | – | 0.16% | 83 |
|
|
2024
Q4 | $391K | Buy |
752
+1
| +0.1% | +$520 | 0.17% | 80 |
|
|
2024
Q3 | $465K | Hold |
751
| – | – | 0.19% | 77 |
|
|
2024
Q2 | $415K | Hold |
751
| – | – | 0.19% | 74 |
|
|
2024
Q1 | $436K | Buy |
+751
| New | +$436K | 0.19% | 74 |
|
|
2023
Q3 | – | Sell |
-760
| Closed | -$396K | – | 88 |
|
|
2023
Q2 | $396K | Hold |
760
| – | – | 0.21% | 73 |
|
|
2023
Q1 | $438K | Buy |
+760
| New | +$438K | 0.24% | 63 |
|
|
2022
Q4 | – | Sell |
-759
| Closed | -$385K | – | 88 |
|
|
2022
Q3 | $385K | Hold |
759
| – | – | 0.23% | 69 |
|
|
2022
Q2 | $412K | Buy |
759
+10
| +1% | +$5.43K | 0.22% | 68 |
|
|
2022
Q1 | $442K | Hold |
749
| – | – | 0.21% | 77 |
|
|
2021
Q4 | $499K | Buy |
749
+1
| +0.1% | +$666 | 0.23% | 76 |
|
|
2021
Q3 | $428K | Buy |
748
+30
| +4% | +$17.2K | 0.21% | 81 |
|
|
2021
Q2 | $386K | Hold |
718
| – | – | 0.18% | 85 |
|
|
2021
Q1 | $328K | Hold |
718
| – | – | 0.17% | 81 |
|
|
2020
Q4 | $334K | Hold |
718
| – | – | 0.18% | 78 |
|
|
2020
Q3 | $317K | Buy |
718
+1
| +0.1% | +$442 | 0.2% | 73 |
|
|
2020
Q2 | $260K | Hold |
717
| – | – | 0.17% | 76 |
|
|
2020
Q1 | $203K | Hold |
717
| – | – | 0.15% | 81 |
|
|
2019
Q4 | $233K | Hold |
717
| – | – | 0.14% | 76 |
|
|
2019
Q3 | $209K | Buy |
717
+1
| +0.1% | +$291 | 0.14% | 79 |
|
|
2019
Q2 | $210K | Buy |
+716
| New | +$210K | 0.14% | 80 |
|